P-047 Perioperative chemotherapy (ECF/FLOT/EOX) for esophagogastric adenocarcinoma: Impact of postoperative chemotherapy on outcome
نویسندگان
چکیده
منابع مشابه
Different regimens of perioperative chemotherapy for esophagogastric and gastric adenocarcinoma: does a triplet therapy with taxane generate a survival benefit?
Transl Gastroenterol Hepatol 2017;2:25 tgh.amegroups.com With new diagnoses in more than 39,000 patients annually, esophagogastric cancer (EGC) is the seventh most common cancer worldwide and a serious health problem. It is a highly lethal disease, causing more than 25,000 deaths per year (1). Surgery with a radical lymphadenectomy is the mainstay of therapy for operable adenocarcinoma of the e...
متن کاملIs EGFR expression altered following postoperative chemotherapy for colorectal adenocarcinoma?
BACKGROUND There is immunohistochemical evidence to suggest that expression of epidermal growth factor receptor (EGFR) in primary colorectal adenocarcinoma predicts its expression in recurrent disease. This study investigates whether postoperative chemotherapy affects the degree of concordance between EGFR statuses of the two tumors. METHODS Thirty-three patients were identified from the file...
متن کاملPostoperative chemotherapy for gastric cancer.
INTRODUCTION Adjuvant chemotherapy for gastric cancer after potentially curative surgery has been under clinical investigation for more than four decades. However, potentially curative resection can be performed in only 30%-50% of patients. The objective of this article is to review briefly the clinical trials available in the current literature using adjuvant cytotoxic chemotherapy in patients...
متن کاملThe impact of perioperative chemotherapy on survival in patients with gastric signet ring cell adenocarcinoma: a multicenter comparative study.
OBJECTIVE The aim of this retrospective study was to evaluate the survival impact of perioperative chemotherapy (PCT) in patients with gastric signet ring cell (SRC) adenocarcinoma. BACKGROUND PCT is a standard treatment for advanced resectable gastric adenocarcinoma (GA). SRC has a worse prognosis compared to non-SRC and the chemosensitivity of SRC is uncertain. METHODS Among 3010 patients...
متن کاملChemotherapy in pancreatic adenocarcinoma.
Pancreatic cancer is a malignancy with a very poor prognosis, even when radically resected. In advanced disease chemotherapy has a role in terms of clinical benefit and symptoms palliation, more than survival advantage. Gemcitabine as a single agent is the first-line standard treatment since 1997. Several trials failed to demonstrate a survival advantage of chemotherapy doublets or gemcitabine ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Oncology
سال: 2015
ISSN: 0923-7534
DOI: 10.1093/annonc/mdv233.47